Whither pulmonary rehabilitation? Will alternative modes help or hurt?

Chronic obstructive pulmonary disease (COPD) causes great misery to those afflicted. While it would be nice to think that a cure is near at hand, this remains only a distant dream. Symptom relief is the best we can do for the time being. We look for therapies to provide important patient-centred benefits such as improved exercise tolerance, reduced dyspnoea and better health-related quality of life. When we consider available therapies, we might consider comparing the magnitude of benefits of bronchodilators with those of pulmonary rehabilitation. A recent informal comparison of these benefits gleaned from meta-analyses in the literature reveals that, for exercise tolerance, dyspnoea and quality of life, the yield of pulmonary rehabilitation is several-fold greater than for bronchodilators [1]. In this analysis, pulmonary rehabilitation benefits well exceed thresholds of clinical importance in all three of these domains. Moreover, over the past 25 years, pulmonary rehabilitation has gained a bulletproof physiological basis [2, 3]; the strategies employed, especially in the area of exercise training, are highly evidence-based.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Editorials Source Type: research

Related Links:

Publication date: Available online 22 May 2019Source: Journal of Environmental SciencesAuthor(s): Rui Chi, Hongyu Li, Qian Wang, Qiangrong Zhai, Daidai Wang, Meng Wu, Qichen Liu, Shaowei Wu, Qingbian Ma, Furong Deng, Xinbiao GuoPrevious studies have reported associations of short-term exposure to different sources of ambient fine particulate matter (PM2.5) and increased mortality or hospitalizations for respiratory diseases. Few studies, however, have focused on the short-term effects of source-specific PM2.5 on emergency room visits (ERVs) of respiratory diseases. Source apportionment for PM2.5 was performed with Positive...
Source: Journal of Environmental Sciences - Category: Environmental Health Source Type: research
DALLAS--Results of 3 studies presented at the American Thoracic Society meeting this week focus on the predictive role of disease exacerbations, machine learning, and Hgb levels in COPD.  
Source: ConsultantLive - Category: Internal Medicine Authors: Tags: Conferences/ATS COPD Respiratory Diseases Source Type: news
Individuals with HDHP more likely to report forgoing care due to costs, cost - related nonadherence
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Emergency Medicine, Nursing, Pulmonology, Conference News, Source Type: news
THURSDAY, May 23, 2019 -- As a rule, high-deductible health plans carry lower premiums than low-deductible plans. But that might not be such a great deal for patients struggling with chronic obstructive pulmonary disease (COPD), new research...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
THURSDAY, May 23, 2019 -- For patients with chronic obstructive pulmonary disease (COPD), high-deductible health plans (HDHPs) are associated with increased likelihood of reporting foregoing care because of costs and cost-related nonadherence,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
(Pulmonx) Piedmont Atlanta Hospital is the first in the state of Georgia to offer a new minimally invasive treatment for emphysema, a severe form of Chronic Obstructive Pulmonary Disease (COPD).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
The mechanisms underlying airflow obstruction in COPD cannot be distinguished by standard spirometry. We ascertain whether mathematical modeling of airway biomechanical properties, as assessed from spirometry,...
Source: Respiratory Research - Category: Respiratory Medicine Authors: Tags: Research Source Type: research
Conclusion: 16 of 19 studies treated by CHM granules only showed positive result in 7 diseases and negative result in 1 disease. 17 of 21 studies treated by combination therapy against conventional therapy showed positive result in 6 diseases and negative result in 3 diseases. However, both the absolute and relative effectiveness of CHM formula granules compared with placebo need to be considered clinically. PMID: 31110552 [PubMed]
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
Acute exacerbations of chronic obstructive pulmonary disease (COPD) often prompt initiation of empirical antibiotic treatment, although in many cases a bacterial pathogen cannot be detected, and viruses may indeed account for a large proportion of episodes. Indeed, data supporting the effectiveness of the broad antibiotic utilisation at exacerbation not requiring intensive care are insufficient. Herein, personalising antibiotic treatment based on a patient's individual risk for bacterial infection has great potential to improve antibiotic stewardship efforts to encourage judicious and correct usage of these agents and miti...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Editorials Source Type: research
A case study from NHS England looks at how the Royal Wolverhampton NHS Trust and Compton Care made sure that patients with chronic obstructive pulmonary disease (COPD) who were approaching the end of their life were accessing the services available to them and had the right support to best manage both their condition and emotional wellbeing.
Source: NHS Networks - Category: UK Health Source Type: news
More News: Chronic Obstructive Pulmonary | National Institute for Health and Clinical Excelle | Rehabilitation | Respiratory Medicine | Sports Medicine | Training | Universities & Medical Training